 |
|
|
| |
Cabotegravir Injections Are More Acceptable Than Lenacapavir Injections Following a Single Dose:
Results From CLARITY, a Randomized Crossover Study of Long-Acting Injectable Antiretrovirals
|
| |
| |
20th European AIDS Conference; October 15-18, 2025; Paris, France
Justine Boles,1 Emilie Elliot,2 Dainielle Fox,3 Apinya Vutikullird,4 Amber Mottola,4 Kim Fletcher,5 Kehui Wang,6 Suryakant Somvanshi,7 Richard Grove,5 Katie Strano,8 Katherine L. Nelson,3 Laure Dupont-Benjamin,9 V. Paul DiMondi,3 Jean van Wyk,1 Harmony P. Garges,6 Kimberley Brown3
1ViiV Healthcare, London, UK; 2ViiV Healthcare, Madrid, Spain; 3ViiV Healthcare, Durham, NC, USA; 4Ark Clinical Research, Long Beach, CA, USA; 5GSK, London, UK; 6GSK, Durham, NC, USA; 7GSK, GCC, Bengaluru, India; 8IQVIA, Kansas City, MO, USA;
9ViiV Healthcare, Rueil-Malmaison, France
|
| |
|
|
|
|
|
